Alliance for Multispecialty Research (AMR) Acquires Affinity Health

AMR Clinical Acquires ClinOhio Research Services

June 29, 2026

Healthcare Services

AMR Clinical (AMR), an integrated multi-site clinical research company, acquired ClinOhio Research Services, a multi-therapeutic clinical research site based in Columbus, Ohio. The acquisition expands AMR’s geographic presence and strengthens capabilities in Dermatology, Women’s Health, and Gastroenterology.

Alliance Clinical Network Merges With Atlas Clinical Research

June 6, 2026

Healthcare Services

Alliance Clinical Network and Atlas Clinical Research announced the completion of a strategic merger to create a larger national clinical research organization. The combined platform is intended to enhance clinical trial recruitment and execution, expand geographic coverage across seven states, and broaden therapeutic capabilities for pharmaceutical sponsors and CRO partners.

Amulet Capital Partners Acquires Alliance Clinical Network

May 22, 2023

Healthcare Services

Amulet Capital Partners has acquired Alliance Clinical Network (ACN), a Dallas-based clinical site platform that owns and operates six research sites across California, Nevada and Texas. ACN will continue to be led by founder and CEO Anthony Abey (who retains a significant ownership stake) and will partner with Amulet to expand its footprint, therapeutic capabilities and strategic acquisitions to serve pharmaceutical sponsors and CROs.

Curewell Capital Majority Recapitalizes AMR (Alliance for Multispecialty Research)

March 18, 2022

Healthcare Services

Alliance for Multispecialty Research (AMR) announced a majority recapitalization led by Curewell Capital, in partnership with existing shareholders and management. The deal is intended to bring new capital and resources to help AMR accelerate growth and expand its footprint for Phase I–IV clinical trial site management.

The IMA Group Acquires Amici Clinical Research

March 2, 2022

Healthcare Services

The IMA Group's Clinical Research division acquired Amici Clinical Research, adding two New Jersey clinical trial sites (Raritan and Hoboken) to IMA's network. The acquisition expands IMA's Northeast footprint and therapeutic capabilities across areas including fatty liver, cardiovascular, pulmonary and neurologic diseases, and supports site-based, hybrid and decentralized trials.

Molina Healthcare Acquires Affinity Health Plan

September 29, 2020

Healthcare Services

Molina Healthcare, Inc. agreed to acquire substantially all assets of Affinity Health Plan for approximately $380 million, funded with cash on hand. The acquisition expands Molina's Medicaid footprint and membership in New York (including New York City and surrounding counties) and is expected to be accretive to adjusted EPS subject to regulatory approvals.